These diseases require specialty treatment typically unavailable at local retail pharmacies or small health systems, making it extremely difficult for many patients to get the care they need.
Kerry Mello-Parker, PharmD
Advertisement
Articles by Kerry Mello-Parker, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
Novavax Enters $530 Million License Agreement with Pfizer for Vaccine Development
4
TopGum Signs $12 Million Letter of Intent to Acquire U.S. Pharmaceutical Manufacturing Operations
5